Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAMTS3 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | ADAMTSL5 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
mRNA | ADAT1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
mRNA | ADAT2 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
mRNA | ADCK2 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
mRNA | ADCY3 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
mRNA | ADCY4 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | ADD1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | ADD2 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | ADGRA3 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |